Plunkett Research Online: Adhera Therapeutics Inc

ADHERA THERAPEUTICS INC (ATRX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Adhera Therapeutics, Inc. (formerly Marina Biotech, Inc.) is an emerging specialty pharmaceutical company focused on fixed dose combination (FDC) therapies in hypertension, with plans to expand the portfolio of drugs it commercializes to include other therapeutic areas. Adhera’s current product is .....


ADHERA THERAPEUTICS INC

Ticker: ATRX
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 919-578-5901
Fax:
Address: 4721 Emperor Blvd., Ste. 350
Durham, NC 27703 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Nancy Phelan CEO
Vuong Trieu Chairman of the Board/Director
See More
Adhera Therapeutics, Inc. (formerly Marina Biotech, Inc.) is an emerging specialty pharmaceutical company focused on fixed dose combination (FDC) therapies in hypertension, with plans to expand the portfolio of drugs it commercializes to include other therapeutic areas. Adhera’s current product is .....See More See More

$USD, In whole numbers 2019 2018 2017 2016 2015 2014 2013
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture